Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Vultaggio · SciRah

Researcher profile · Semantic Scholar

A. Vultaggio

Share profile

A. Vultaggio — researcher profile on SciRah

h-index: 41
Works: 169
Citations: 4,974

Most-cited papers

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
A. Mazzoni, Lorenzo Salvati, L. Maggi, M. Capone +25 more
2020Journal of Clinical Investigation453 citations Open access
Semantic Scholar
In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper
C. Mayorga, Gülfem E. Çelik, P. Rouzaire, P. Whitaker +17 more
2016Allergy. European Journal of Allergy and Clinical Immunology210 citations Open access
Semantic Scholar
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
C. Kaegi, B. Wuest, J. Schreiner, U. Steiner +4 more
2019Frontiers in Immunology204 citations Open access
Semantic Scholar
Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
A. Matucci, A. Vultaggio, E. Maggi, I. Kasujee
2018Respiratory Research181 citations Open access
Semantic Scholar
Hypersensitivity reactions to biologicals: An EAACI position paper
S. Bavbek, M. Pagani, E. Álvarez-Cuesta, M. Castells +5 more
2021Allergy. European Journal of Allergy and Clinical Immunology84 citations Open access
Semantic Scholar
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
A. Vultaggio, I. Agache, C. Akdis, M. Akdiş +21 more
2020Allergy. European Journal of Allergy and Clinical Immunology78 citations Open access
Semantic Scholar
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
C. Milito, V. Lougaris, G. Giardino, Alessandra Punziano +32 more
2021Journal of Allergy and Clinical Immunology: In Practice75 citations Open access
Semantic Scholar
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies.
C. Milito, Federica Pulvirenti, Francesco Cinetto, V. Lougaris +15 more
2019Journal of Allergy and Clinical Immunology71 citations Open access
Semantic Scholar
Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma.
A. Matucci, E. Maggi, A. Vultaggio
2019Respiratory Medicine62 citations Open access
Semantic Scholar
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
A. Vultaggio, E. Vivarelli, G. Virgili, E. Lucenteforte +24 more
2020Journal of Allergy and Clinical Immunology: In Practice60 citations Open access
Semantic Scholar
Factors reducing omalizumab response in severe asthma.
B. Sposato, M. Scalese, M. Milanese, S. Masieri +10 more
2018European journal of internal medicine60 citations
Semantic Scholar
Biologicals in atopic disease in pregnancy: An EAACI position paper
Birgit Pfaller, Juan José Yepes-Nuñez, I. Agache, C. Akdis +21 more
2020Allergy. European Journal of Allergy and Clinical Immunology55 citations Open access
Semantic Scholar
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium
Signe Hässler, D. Bachelet, Julianne Duhaze, N. Szely +57 more
2020PLoS Medicine54 citations Open access
Semantic Scholar
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
E. Nettis, L. Brussino, V. Patella, L. Bonzano +56 more
2022Clinical and Molecular Allergy50 citations Open access
Semantic Scholar
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
A. Matucci, A. Vultaggio, R. Danesi
2018Respiratory Research50 citations Open access
Semantic Scholar
Omalizumab dampens type 2 inflammation in a group of long‐term treated asthma patients and detaches IgE from FcεRI
L. Maggi, Beatrice Rossettini, Gianni Montaini, A. Matucci +8 more
2018European Journal of Immunology49 citations Open access
Semantic Scholar
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
M. Caminati, A. Vultaggio, A. Matucci, G. Senna +15 more
2020Respiratory Medicine48 citations Open access
Semantic Scholar
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab
A. Vultaggio, M. Accinno, E. Vivarelli, Valentina Mecheri +7 more
2023Allergy. European Journal of Allergy and Clinical Immunology45 citations Open access
Semantic Scholar
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
A. Matucci, S. Bormioli, F. Nencini, F. Chiccoli +3 more
2021International Journal of Molecular Sciences45 citations Open access
Semantic Scholar
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
A. Vultaggio, F. Nencini, S. Bormioli, E. Vivarelli +5 more
2020Allergy Asthma and Immunology Research43 citations Open access
Semantic Scholar
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients
A. Matucci, F. Nencini, G. Maggiore, F. Chiccoli +13 more
2022Clinical and Experimental Allergy42 citations Open access
Semantic Scholar
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study
F. Menzella, E. Bargagli, M. Aliani, P. Bracciale +21 more
2022Respiratory Research41 citations Open access
Semantic Scholar
COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
A. Matucci, M. Caminati, E. Vivarelli, A. Vianello +16 more
2020Allergy. European Journal of Allergy and Clinical Immunology38 citations
Semantic Scholar
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
A. Vultaggio, M. Aliani, E. Altieri, P. Bracciale +19 more
2023Respiratory Research36 citations Open access
Semantic Scholar
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
L. Klimek, O. Pfaar, M. Worm, T. Eiwegger +89 more
2020Allergologie select35 citations Open access
Semantic Scholar
Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication.
Bernard Yu-Hor Thong, A. Vultaggio, T. Rerkpattanapipat, R. Schrijvers
2021Journal of Allergy and Clinical Immunology: In Practice32 citations Open access
Semantic Scholar
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
A. Vultaggio, M. Perlato, F. Nencini, E. Vivarelli +2 more
2021Frontiers in Immunology32 citations Open access
Semantic Scholar
Mechanisms of Drug Desensitization: Not Only Mast Cells
A. Vultaggio, A. Matucci, F. Nencini, S. Bormioli +2 more
2020Frontiers in Pharmacology31 citations Open access
Semantic Scholar
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.
F. Nencini, A. Vultaggio, S. Pratesi, D. Cammelli +7 more
2018Journal of Allergy and Clinical Immunology: In Practice28 citations
Semantic Scholar
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
M. D'Amato, F. Menzella, E. Altieri, E. Bargagli +21 more
2022Frontiers in Allergy25 citations Open access
Semantic Scholar
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
A. Matucci, E. Vivarelli, F. Nencini, E. Maggi +1 more
2021Biomedicines24 citations Open access
Semantic Scholar
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)
M. Caminati, L. Brussino, Matilde Carlucci, P. Carlucci +28 more
2024Cells22 citations Open access
Semantic Scholar
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report
P. Orlando, G. Licci, Donald Kuitche, A. Matucci +3 more
2023European Archives of Oto-Rhino-Laryngology22 citations
Semantic Scholar
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
J. Bousquet, I. Agache, H. Blain, M. Jutel +145 more
2021Allergy. European Journal of Allergy and Clinical Immunology21 citations Open access
Semantic Scholar
Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study
G. Vitiello, Carolina Orsi Battaglini, Giulia Carli, A. Radice +6 more
2018Angiology18 citations Open access
Semantic Scholar
Severe asthma and biologics: managing complex patients.
A. Matucci, C. Micheletto, A. Vultaggio
2022Journal of investigational allergology & clinical immunology16 citations Open access
Semantic Scholar
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
C. Caruso, P. Cameli, E. Altieri, M. Aliani +21 more
2022Frontiers in Medicine16 citations Open access
Semantic Scholar
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia?
Leonardo Fei, Gabriele Santarelli, G. D'Anna, Sandra Moretti +10 more
2021Panminerva Medica (Testo stampato)16 citations
Semantic Scholar
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
A. Matucci, F. Liotta, E. Vivarelli, L. Dies +6 more
2018Frontiers in Immunology16 citations Open access
Semantic Scholar
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study
P. Orlando, E. Vivarelli, A. Minzoni, G. Licci +5 more
2024European Archives of Oto-Rhino-Laryngology15 citations Open access
Semantic Scholar
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience
A. Matucci, E. Vivarelli, S. Bormioli, N. Francesca +6 more
2022Journal of Asthma15 citations
Semantic Scholar
IL-10–Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed Patients
A. Vultaggio, F. Nencini, S. Pratesi, D. Cammelli +4 more
2017Journal of Immunology15 citations Open access
Semantic Scholar
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
A. Vultaggio, F. Nencini, S. Bormioli, E. Silvestri +4 more
2021Scientific Reports14 citations Open access
Semantic Scholar
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
S. Pratesi, F. Nencini, F. Grosso, L. Dies +5 more
2019Frontiers in Immunology14 citations Open access
Semantic Scholar
Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia
G. Spadaro, A. Vultaggio, A. Bosi, D. Reichert +14 more
2017International Immunopharmacology13 citations
Semantic Scholar
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
M. Spinicci, I. Vellere, L. Graziani, Marta Tilli +34 more
2021Open Forum Infectious Diseases12 citations Open access
Semantic Scholar
Effect of dupilumab treatment in a severe asthma patient with EGPA.
A. Matucci, S. Bormioli, L. Bercich, C. Comin +3 more
2021Journal of Allergy and Clinical Immunology: In Practice12 citations
Semantic Scholar
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
R. Scarpa, Federica Pulvirenti, A. Pecoraro, A. Vultaggio +15 more
2020Frontiers in Immunology12 citations Open access
Semantic Scholar
Hypersensitivity reactions to biologics used in rheumatology
A. Matucci, F. Nencini, E. Maggi, A. Vultaggio
2019Expert Review of Clinical Immunology12 citations
Semantic Scholar
Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS)
A. Vultaggio, C. Azzari, S. Ricci, B. Martire +10 more
2018Journal of Clinical Immunology12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Matucci×41
Invite
A. Matucci — researcher profile on SciRah
E. Maggi×18
Invite
E. Maggi — researcher profile on SciRah
E. Vivarelli×17
Invite
E. Vivarelli — researcher profile on SciRah
F. Nencini×13
Invite
F. Nencini — researcher profile on SciRah

×12

Invite

P. Parronchi — researcher profile on SciRah

S. Del Giacco×8

Invite

S. Del Giacco — researcher profile on SciRah

Oliviero Rossi×7

Invite

Oliviero Rossi — researcher profile on SciRah

Invite

L. Cosmi — researcher profile on SciRah

Invite

L. Brussino — researcher profile on SciRah

Invite

G. Senna — researcher profile on SciRah

Invite

S. Bormioli — researcher profile on SciRah

Invite

G. Spadaro — researcher profile on SciRah